Creamedix becomes part of MicroMol and the Tentamus Group
(PresseBox) - The medical device testing laboratory Creamedix in Weingarten, Germany, is joining MicroMol in Karlsruhe and thus also the Tentamus Group.
Dr. Dominik Herzog, Managing Director of MicroMol GmbH announced the move in Weingarten. ?We are very pleased to welcome Creamedix on board of MicroMol and Tentamus. Creamedix? strong expertise in biocompatibility testing according to ISO 10993 of medical devices, especially its expertise in haemocompatibility testing, her increasing the high expertise of the Tentamus laboratory network in the field of pharmaceutical and medical industry.?
About Creamedix
Creamedix, an ISO 17025 accredited laboratory in Weingarten, Germany, analyses medical devices and raw materials on behalf of companies in the healthcare industry. Creamedix biolab?s expertise lies in biocompatibility testing according to ISO 10993 and is particularly strong in the field of in-vitro based testing systems as an alternative to animal based testing. Its services include in-vitro
For further information visit: www.creamedix.eu
About MicroMol GmbH
MicroMol, a Tentamus lab, is a bioanalytical service provider for the medical device and pharmaceutical industry. Its work focuses on analytical services in the area of microbiology, bioanalytics, and biological safety/biocompatibility. With around 25 employees in Karlsruhe, Germany, MicroMol supports small biotech start-ups, medium sized companies, and large cooperations in their specific analytical needs from method development, method validation/verification to routine analysis.
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 52 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food&feed, pharmaceuticals&medical, agrochemicals, cosmetics, agriculture&environment and nutraceutical&supplements). Tentamus Group is represented in over 52 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Datum: 04.07.2019 - 02:00 Uhr
Sprache: Deutsch
News-ID 1550441
Anzahl Zeichen: 2774
contact information:
Contact person:
Town:
Karlsruhe/ Weingarten (Germany)
Phone:
Kategorie:
Energy & Utilities
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 565 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Creamedix becomes part of MicroMol and the Tentamus Group
"
steht unter der journalistisch-redaktionellen Verantwortung von
Tentamus Group GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
